Revolution Medicines, Inc. (Nasdaq: RVMD) announced that the U.S. Food and Drug Administration has approved RASONQUE (daraxonrasib), a once-daily oral ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA